£790.00

It has never been this cheap. We have no record of a lower price.

£790 today · cheaper than every other day in the last 3 months

2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 87 days · 87 data points (no recent data)

Historical
Generating forecast…
£790.00 £750.50 £766.30 £782.10 £797.90 £813.70 £829.50 11 August 2026 01 September 2026 23 September 2026 14 October 2026 05 November 2026
View at Amazon ↗

Price data checked 4 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 87 days • 1 price levels

Days at Price
87 days 0 22 44 65 87 £790 Days at Price

Price Analysis

Most common price: £790 (87 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 87 days

Description

This comprehensive study provides a global outlook for idiopathic pulmonary fibrosis spanning more than 190 countries from 2025 to 2030. The report uses econometric models to project fundamental economic dynamics within and across individual nations to create accurate latent demand estimates. Readers gain access to potential industry earnings (P.I.E.) expressed in millions of U.S. dollars for each reported year. The data includes the percent share each country holds relative to its specific region and the global market. These comparative benchmarks allow for a quick assessment of a country's market position against others, providing a detailed view of the economic landscape for this condition.

Key Features

Covers the world outlook for idiopathic pulmonary fibrosis across more than 190 countries.

Provides estimates for latent demand and potential industry earnings (P.I.E.) in millions of U.S. dollars.

Includes percent share data for each country regarding its specific region and the entire globe.

Uses econometric models to project fundamental economic dynamics within and across different countries.

Offers comparative benchmarks to help readers gauge a country's market position vis-a-vis others.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
07 May 2024

Similar Products You Might Like

World Outlook for Idiopathic Pulmonary Fibrosis Treatments
99% match

World Outlook for Idiopathic Pulmonary Fibrosis Treatments

£790.00 05 Nov 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India
99% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India

£515.00 02 Sep 2026
The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis
99% match

The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis

Price unavailable
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India
99% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India

£515.00 02 Sep 2026
The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis Treatments
99% match

The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis Treatments

Price unavailable
Pulmonary Fibrosis Treatment Outlook 2023-2028 - US Study
99% match

Pulmonary Fibrosis Treatment Outlook 2023-2028 - US Study

£520.00 05 Nov 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China
99% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China

£495.00 28 Aug 2026
The 2023 Report on Idiopathic Pulmonary Fibrosis: World Market Segmentation by City
99% match

The 2023 Report on Idiopathic Pulmonary Fibrosis: World Market Segmentation by City

£795.00 29 Oct 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in Japan
99% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in Japan

£495.00 02 Sep 2026
World Outlook for Pulmonary Fibrosis Treatments 2025-2030
99% match

World Outlook for Pulmonary Fibrosis Treatments 2025-2030

Price unavailable
2025-2030 World Outlook - Anti-IPF Drug Market Report
98% match

2025-2030 World Outlook - Anti-IPF Drug Market Report

Price unavailable
The 2023-2028 World Outlook for Pulmonary Fibrosis Treatments
98% match

The 2023-2028 World Outlook for Pulmonary Fibrosis Treatments

Price unavailable
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments for US Zip Codes
98% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments for US Zip Codes

£490.00 28 Aug 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in China
98% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in China

£495.00 06 Nov 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in Japan
98% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in Japan

£495.00 02 Sep 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments for US Zip Codes
98% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments for US Zip Codes

£490.00 27 Aug 2026
The 2013-2018 Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics in India
97% match

The 2013-2018 Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics in India

£495.00 04 Nov 2026
The 2016-2021 World Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics
97% match

The 2016-2021 World Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics

£995.00 29 Oct 2026
World Outlook for Cystic Fibrosis Drugs 2025-2030 Report
97% match

World Outlook for Cystic Fibrosis Drugs 2025-2030 Report

Price unavailable
World Outlook for Cystic Fibrosis Therapeutics 2025-2030
97% match

World Outlook for Cystic Fibrosis Therapeutics 2025-2030

Price unavailable
COPD Treatment Outlook 2023-2028 - US Zip Code Analysis
97% match

COPD Treatment Outlook 2023-2028 - US Zip Code Analysis

£490.00 02 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States

£520.00 02 Oct 2026
India Respiratory Disorder Treatment Outlook 2023-2028 Study
97% match

India Respiratory Disorder Treatment Outlook 2023-2028 Study

£515.00 03 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India

£515.00 01 Oct 2026